Open AccessLow applicability of the ��six-and-twelve score� in hepatocellular carcinoma treated with drug-eluting beads transarterial chemoembolization
Author(s) -
María Pipa-Muñiz,
Andrés Castaño-García,
Susana Sanmartino,
Alicia Mesa,
Carmen Álvarez-Navascués,
M.L. González-Diéguez,
Valle Cadahía-Rodrigo,
Mario Ernesto Piscoya-Díaz,
Serafín Marcos Costilla-García,
Manuel Rodrı́guez,
Marı́a Varela
Publication year - 2021
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2021.7696/2020
Subject(s) - medicine , hepatocellular carcinoma , gastroenterology , retrospective cohort study , liver transplantation , observational study , transplantation
The effectiveness of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) depends on the selection of suitable patients. The ''Six-and-twelve score" distinguishes three groups of ideal patients with different overall survival, based on the sum of the number and size of tumors. This may impact on clinical practice and trial design. The aim of this study was to assess the reproducibility and prognostic value of the model in western patients treated with Drug-Eluting Beads (DEB)-TACE.